ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Technology

Google fails to make fresh Himax investment but remains Glass partners

21 Oct 2014 @ 22:57
Google Chooses Not to Exercise Its Investment Option, but Himax and Google to Remain Strategic Partners on Google Glass Himax Technologies, Inc. (Nasdaq:HIMX), a leading supplier and fabless manufacturer of display drivers and other semiconductor products, today announced that Google Inc. has decided not to exercise its previously issued purchase option to make an additional […]
 

IBM Shares Plummet On Q3 Results

20 Oct 2014 @ 21:37
The share price of IBM (NYSE:IBM) plummeted upon release of its third quarter results this morning. IBM closed at 182.05 on Friday, October 17th. The value of the company’s shares dropped in early trading to open today at 166.93. The share price has held fairly steady during the day with about an hour remaining. It […]
 

Aeroject secure NASA contract to power Mars mission

19 Oct 2014 @ 22:17
Is there life on Aeroject? Aerojet Rocketdyne, a GenCorp (NYSE:GY) company, recently received a contract from NASA’s Jet Propulsion Laboratory to supply the thrusters that would help land the next rover on Mars after it is launched in 2020. Under a contract from the U.S. Department of Energy, Aerojet Rocketdyne also would supply the power […]
 

Aeorema Communications issue FY final results

16 Oct 2014 @ 23:09
Final Results Aeorema Communications, an AIM-traded live events agency, has announced its results for the year ended 30 June 2014. Overview: · Positive progress made towards building the Group as a leading provider of live events · Increased profits before tax from continuing operations to £504,841 (2013: £358,864) · Increased revenues to £4,764,584 (2013: 3,992,751) […]
 

Tesla Better for Buy and Hold

16 Oct 2014 @ 20:12
It was big news for some this morning that the Tesla share price (NASDAQ:TSLA) opened lower for the second day in a row. Personally, I find it bigger news that it is now almost 2:30 p.m. on the U.S. eastern seaboard and TSLA has already climbed back to 229.63, nearly to yesterday’s close of 229.70, […]
 

Northrop Grumman unveils new vehicle

14 Oct 2014 @ 21:31
Northrop Grumman Corporation (NYSE:NOC) has unveiled its High Mobility Multipurpose Wheeled Vehicle (HMMWV) modernization solution at the Association of the United States Army conference in Washington, D.C. “The HMMWV has had an enduring role in the U.S. Army, U.S. Marine Corps and across the international ground forces community for decades,” said Frank Simpkins, director, land...
 

SternoCandleLamp acquires Compass?

13 Oct 2014 @ 23:23
Will it light up investor’s portfolios? SternoCandleLamp (SCL) is pleased to announce it has been acquired by Compass Diversified Holdings (NYSE:CODI), an owner of leading middle market businesses. Unlike many traditional private equity firms, CODI maintains a longer term outlook as to the ownership of businesses where such an outlook is required to maximize stakeholder […]
 

Sucampo settles AMITIZA patent litigation

12 Oct 2014 @ 10:53
Company Receives Additional Paragraph IV Notice Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo, R-Tech Ueno, Ltd. (RTU), Takeda Pharmaceutical Company Limited (Takeda) and certain affiliates of Takeda have entered into a settlement and license agreement with Anchen Pharmaceuticals, Inc., Par Pharmaceutical, Inc., and Par...
 

EBay Stock Finds Support as the Price Rallies

09 Oct 2014 @ 10:46
EBay stock (NASDAQ:EBAY) has found support around the EMA 200, as a potential death cross was averted and the price rallies from there. The price gapped up seriously at the end of September 2014, and it later dropped. But the price has turned upwards after testing the EMA 200, which acts as a great support […]
 

Coronado Biosciences forms subsidiary to license products

08 Oct 2014 @ 23:03
Goal is to “aggregate a strong line of dermatologics” Coronado Biosciences, Inc. (Nasdaq:CNDO) has formed a wholly owned subsidiary, Journey Medical Corporation (JMC), to acquire and license dermatology products. Under the leadership of Claude Maraoui, CEO, JMC will begin building a portfolio of dermatological assets focused on acne, steroid responsive dermatoses, pigmentation and...
 
 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com